Advertisement
AMS vs PNTG
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMS is a Hold and PNTG is a Buy.
AMS sees its Stochastic Oscillator recovers from oversold territory
On October 22, 2026, the Stochastic Oscillator for AMS moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 66 instances where the indicator left the oversold zone. In 49 of the 66 cases the stock moved higher in the following days. This puts the odds of a move higher at over 74%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AMS's RSI Oscillator exited the oversold zone, 5 of 8 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 62%.
The Moving Average Convergence Divergence (MACD) for AMS just turned positive on October 27, 2026. Looking at past instances where AMS's MACD turned positive, the stock continued to rise in 32 of 45 cases over the following month. The odds of a continued upward trend are 71%.
Following a +6.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMS advanced for three days, in 127 of 200 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMS as a result. In 89 of 138 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
AMS broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AMS entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.365) is normal, around the industry mean (204.120). P/E Ratio (-4.885) is within average values for comparable stocks, (19.084). Projected Growth (PEG Ratio) (0.070) is also within normal values, averaging (2.498). Dividend Yield (0.150) settles around the average of (0.091) among similar stocks. P/S Ratio (0.313) is also within normal values, averaging (2.688).
The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. AMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
PNTG in upward trend: price rose above 50-day moving average on October 05, 2026
PNTG moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend. In 33 of 40 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 82%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for PNTG just turned positive on October 12, 2026. Looking at past instances where PNTG's MACD turned positive, the stock continued to rise in 40 of 52 cases over the following month. The odds of a continued upward trend are 77%.
Following a +1.94% 3-day Advance, the price is estimated to grow further. Considering data from situations where PNTG advanced for three days, in 243 of 312 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Aroon Indicator entered an Uptrend today. In 183 of 236 cases where PNTG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 65 cases where PNTG's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 71%.
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PNTG as a result. In 61 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 66%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PNTG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
PNTG broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. PNTG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 53 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 72 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.051) is normal, around the industry mean (204.120). P/E Ratio (44.319) is within average values for comparable stocks, (19.084). Projected Growth (PEG Ratio) (2.017) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.091) among similar stocks. P/S Ratio (1.373) is also within normal values, averaging (2.688).
AMS | PNTG | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 4 Undervalued | 86 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 53 | |
SMR RATING 1..100 | 93 | 72 | |
PRICE GROWTH RATING 1..100 | 76 | 39 | |
P/E GROWTH RATING 1..100 | 27 | 13 | |
SEASONALITY SCORE 1..100 | 50 | 35 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AMS's Valuation (4) in the Medical Or Nursing Services industry is significantly better than the same rating for PNTG (86) in the null industry. This means that AMS’s stock grew significantly faster than PNTG’s over the last 12 months.
PNTG's Profit vs Risk Rating (53) in the null industry is somewhat better than the same rating for AMS (100) in the Medical Or Nursing Services industry. This means that PNTG’s stock grew somewhat faster than AMS’s over the last 12 months.
PNTG's SMR Rating (72) in the null industry is in the same range as AMS (93) in the Medical Or Nursing Services industry. This means that PNTG’s stock grew similarly to AMS’s over the last 12 months.
PNTG's Price Growth Rating (39) in the null industry is somewhat better than the same rating for AMS (76) in the Medical Or Nursing Services industry. This means that PNTG’s stock grew somewhat faster than AMS’s over the last 12 months.
PNTG's P/E Growth Rating (13) in the null industry is in the same range as AMS (27) in the Medical Or Nursing Services industry. This means that PNTG’s stock grew similarly to AMS’s over the last 12 months.
| AMS | PNTG | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 63% | N/A |
| Stochastic ODDS (%) | 3 days ago 74% | 3 days ago 71% |
| Momentum ODDS (%) | 3 days ago 64% | 3 days ago 66% |
| MACD ODDS (%) | 3 days ago 71% | 3 days ago 77% |
| TrendWeek ODDS (%) | 3 days ago 67% | 3 days ago 72% |
| TrendMonth ODDS (%) | 3 days ago 65% | 3 days ago 79% |
| Advances ODDS (%) | 5 days ago 63% | 4 days ago 78% |
| Declines ODDS (%) | 13 days ago 65% | 14 days ago 73% |
| BollingerBands ODDS (%) | 3 days ago 79% | 3 days ago 71% |
| Aroon ODDS (%) | 3 days ago 68% | 3 days ago 78% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMS’s FA Score shows that 2 FA rating(s) are green while PNTG’s FA Score has 1 green FA rating(s).
- AMS’s FA Score: 2 green, 3 red.
- PNTG’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMS’s TA Score shows that 4 TA indicator(s) are bullish while PNTG’s TA Score has 4 bullish TA indicator(s).
- AMS’s TA Score: 4 bullish, 4 bearish.
- PNTG’s TA Score: 4 bullish, 4 bearish.
Price Growth
AMS (@Hospital/Nursing Management) experienced а +0.79% price change this week, while PNTG (@Hospital/Nursing Management) price change was -0.53% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +0.92%. For the same industry, the average monthly price growth was +4.04%, and the average quarterly price growth was +19.38%.
Reported Earning Dates
AMS is expected to report earnings on Nov 12, 2026.
PNTG is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Hospital/Nursing Management (+0.92% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
Advertisement
AMS and
Correlation & Price change
A.I.dvisor tells us that AMS and BKD have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMS and BKD's prices will move in lockstep.
| Ticker / NAME | Correlation To AMS | 1D Price Change % | ||
|---|---|---|---|---|
| AMS | 100% | +0.79% | ||
| BKD - AMS | 23% Poorly correlated | +1.17% | ||
| PNTG - AMS | 21% Poorly correlated | -1.93% | ||
| ADUS - AMS | 15% Poorly correlated | +0.97% | ||
| HCA - AMS | 14% Poorly correlated | -1.02% | ||
| THC - AMS | 11% Poorly correlated | +0.99% | ||
More | ||||
PNTG and
Correlation & Price change
A.I.dvisor indicates that over the last year, PNTG has been loosely correlated with UHS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PNTG jumps, then UHS could also see price increases.
| Ticker / NAME | Correlation To PNTG | 1D Price Change % | ||
|---|---|---|---|---|
| PNTG | 100% | -1.93% | ||
| UHS - PNTG | 42% Loosely correlated | -0.32% | ||
| AVAH - PNTG | 41% Loosely correlated | -0.75% | ||
| ADUS - PNTG | 40% Loosely correlated | +0.97% | ||
| ENSG - PNTG | 40% Loosely correlated | -2.58% | ||
| CON - PNTG | 40% Loosely correlated | -2.11% | ||
More | ||||